ASML vs BOLT · P/E 57, $665.37B cap vs rev $7.7M
ASML Holding NV ADR (ASML) versus Bolt Biotherapeutics (BOLT) — a side-by-side from cached financials, not a winner call.
ASML Holding NV ADR (ASML) is a semiconductor equipment & materials company listed on US.
Bolt Biotherapeutics (BOLT) is a biotechnology company listed on US.
ASML does not have a complete income-statement cache yet.
Latest reported BOLT revenue for 2024-12-31 was $7.7M. Net income was -$63.1M. Revenue was down 2.4% from 2023-12-31 to 2024-12-31. BOLT currently screens at market cap $11.3M.
ASML currently screens at market cap $665.37B and trailing P/E 57.5. BOLT currently screens at market cap $11.3M.
Not investment advice. Open the ASML and BOLT stock pages for the full models.
Not investment advice.